Jared T. Hammill

Jared T. Hammill

Auto-generated profile, based on publicly available information

Jared T. Hammill


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2007 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JJJennifer C. Jackson
Jennifer C. Jackson
JHJared T. Hammill
Jared T. Hammill
RMRyan A. Mehl
Ryan A. Mehl

18 October 2007 in Nature Protocols
Verified
Journal Article
Closed access
JHJared T Hammill
Jared T Hammill
SMShigeki Miyake-Stoner
Shigeki Miyake-Stoner
JHJennifer L Hazen
Jennifer L Hazen
JJJennifer C Jackson
Jennifer C Jackson
RMRyan A Mehl
Ryan A Mehl

3 June 2009 in Biochemistry
Verified
Journal Article
Closed access
SMShigeki J. Miyake-Stoner
Shigeki J. Miyake-Stoner
AMAndrew M. Miller
Andrew M. Miller
JHJared T. Hammill
Jared T. Hammill
JPJennifer C. Peeler
Jennifer C. Peeler
KHKenneth R. Hess
Kenneth R. Hess
SBScott H. Brewer
Scott H. Brewer

5 June 2017 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
DSDaniel C Scott
Daniel C Scott
JHJared T Hammill
Jared T Hammill
JMJaeki Min
Jaeki Min
DRDavid Y Rhee
David Y Rhee
MCMichele Connelly
Michele Connelly
RGR Kip Guy
R Kip Guy
High-throughput screening and structure-guided design identified small-molecule inhibitors that prevent the interaction between N-terminally acetylated E2 conjugating enzyme UBE2M and DCN1, an E3 ligase for the ubiquitin-like protein Nedd8. N-terminal acetylation is an abundant modification influencing protein functions. Because ∼80% of mammalian cytosolic proteins are N-terminally acetylated, this modification is potentially an untapped target for chemical control of their functions. Structural studies have revealed that, like lysine acetylation, N-terminal acetylation converts a positively charged amine into a hydrophobic handle that mediates protein interactions; hence, this modification may be a druggable target. We report the development of chemical probes targeting the N-terminal acetylation–dependent interaction between an E2 conjugating enzyme (UBE2M or UBC12) and DCN1 (DCUN1D1), a subunit of a multiprotein E3 ligase for the ubiquitin-like protein NEDD8. The inhibitors are highly selective with respect to other protein acetyl-amide–binding sites, inhibit NEDD8 ligation in vitro and in cells, and suppress anchorage-independent growth of a cell line with DCN1 amplification. Overall, our data demonstrate that N-terminal acetyl-dependent protein interactions are druggable targets and provide insights into targeting multiprotein E2–E3 ligases.

18 January 2010 in Biochemistry
Verified
Journal Article
Closed access
SMShigeki J. Miyake-Stoner
Shigeki J. Miyake-Stoner
CRChristian A. Refakis
Christian A. Refakis
JHJared T. Hammill
Jared T. Hammill
HLHrvoje Lusic
Hrvoje Lusic
JHJennifer L. Hazen
Jennifer L. Hazen
RMRyan A. Mehl
Ryan A. Mehl

26 March 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JHJared T. Hammill
Jared T. Hammill
DBDeepak Bhasin
Deepak Bhasin
DSDaniel C. Scott
Daniel C. Scott
JMJaeki Min
Jaeki Min
YCYizhe Chen
Yizhe Chen
RGR. Kiplin Guy
R. Kiplin Guy